AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Mayo Clinic at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Mayo Clinic brings 15 presentations to AMP 2026 in Seattle. Its program centres on measurable residual disease testing in blood cancers, long-read sequencing and foundation models for molecular informatics. It also covers DNA methylation and artificial intelligence for classifying central nervous system tumours, and weighs FISH against RNA sequencing for structural variants in solid tumours.

OrganizationAMP 2026 Attendance
Mayo Clinic
Rochester, MN
Med centres
Academic medical center and health system whose laboratories develop and run clinical molecular and genomic testing.
Workshop
Wed, Nov 11
12:00pm–12:50pm
Genome as a Platform: Advancing MRD Research with Illumina Whole Genome Sequencing Oncology Prep
Whole-genome sequencing as a single platform for molecular residual disease research, with early analytical performance data.
Workshop hosted by Illumina
Workshop
Wed, Nov 11
2:00pm–3:50pm
Evaluation of the BioCode® STI + Resistance Panel for STI Detection, Antimicrobial Resistance Markers, and Multiplex STI Panels Reimbursement Considerations
Performance of a multiplex panel detecting chlamydia, gonorrhea, mycoplasma and trichomonas with resistance markers, plus reimbursement.
Workshop hosted by Applied BioCode
Talk
Thu, Nov 12
10:45am–11:15am
New Insights from Gene Expression Profiling of Anaplastic Large Cell Lymphoma
Gene expression profiling of anaplastic large cell lymphoma and the two newly defined types, I and II, with distinct targetable biology.
Hematopathology
Workshop
Thu, Nov 12
6:15pm–6:45pm
Unlocking New Possibilities in Myeloid Malignancies MRD Assessment with NGS
An NGS assay for measurable residual disease in myeloid cancers, covering its gene content, workflow and reported performance.
Workshop hosted by Thermo Fisher Scientific
Talk
Sat, Nov 14
10:15am–10:45am
FISH vs. RNA sequencing for Structural Variant Detection in Solid Tumors: Strengths and Limitations
Case-based comparison of break-apart FISH and RNA sequencing for finding gene rearrangements in solid tumors, including FFPE pitfalls.
Hematopathology · Lab Management · Solid Tumors
Session
Sat, Nov 14
10:15am–11:45am
Foundation Models in Molecular
Informatics
  1. 10:15am–11:00amFrom AI Promise to Clinical Practice: Which Genomic Foundation Models Can You Trust in Molecular Testing?The University of Texas MD Anderson Cancer Center
  2. 11:00am–11:45amScoring Variants with Genomic Foundation ModelsGenomics England
Talk
Sat, Nov 14
2:30pm–3:00pm
CNVpytor: Comprehensive Detection, Annotation, and Visualization of Germline and Somatic Copy Number Variations
CNVpytor, a tool combining read depth and B-allele frequency to call and visualize germline and somatic copy number changes.
Informatics

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Mayo Clinic

Tell us what you sell and we’ll find the people at Mayo Clinic most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction